SNN (Smith & Nephew Pl)
All Pro Portfolios with SNN

People owning SNN also tend to own:: AESBLUDCNICOHCRSCSCOCTSH

All Do-It-Yourself Portfolios with SNN
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:thewookie

Date:03 10 09

Exposure to aging baby boomers running themselves into the ground.

Not yet rated
Rate now:

By:holden33

Date:12 20 08

baby boomers aging new products coming

Not yet rated
Rate now:

By:barrons2

Date:07 10 08

Smith & Nephew has a diversified portfolio of health care businesses. It gets 37% of its revenues from orthopedic reconstruction and it has a orthopedic trauma, endoscopy, and advanced wound care business as well. Cramer said all of its businesses are good and stable.

Not yet rated
Rate now:

By:just some pharmacist

Date:11 19 07

It's not drugs, it's not hospitals, it's the indispensible business of health care supplies.

Not yet rated
Rate now:

By:kfwinona

Date:04 18 07

projected growth of orthopedics markets; specific hip and shoulder innovations; dividend history and company history

Not yet rated
Rate now:

By:arnabdgp

Date:04 06 07

Last month, Smith and Nephew agreed to buy Swiss-based Plus Orthopaedics and leapt over Biomet to become the world's fourth largest hip and knee implant company, grabbing about 12% of the market.

Not yet rated
Rate now:

By:Guest

Date:03 28 07

Smith & Nephew (SNN), which just acquired Plus Orthopedics. That deal moves the London company into the No. 4 slot in the worldwide orthopedics market. As in most markets, the biggest share of the profits go to the top players, so the company's move up the orthopedics food chain will be a significant driver of increased profit margins in an orthopedics market that will see big growth as the world's population ages.

Not yet rated
Rate now:

Why I Hate This Stock

Comments not available
Add Your Comments  
Stock SNN
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Cartoon Thread
11.15.07 | 20:31 PM From author Peter near Matanzas Inlet
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. Curious on everyone's thoughts o...
07.04.09 | 07:47 AM Asked by blitz373

A. I have a small position, which I will
most likely get stopped out of on
Monday. I'm hearing that analyst think
that they are going to miss on earnings.
I'm going to sit tight and let the
market take me out.

today 's lists
TSC Ratings Upgrades

These stocks were upgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more

Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on July 1, 2009. more

52-Week Lows

Here is a list of some of the biggest stocks that hit 52-week lows as of July 1, 2009. more